Sanofi and Regeneron expand alliance in $8B deal

Sanofi and Regeneron signed an $8 billion deal to expand their immunology alliance, the companies announced Thursday.

Why it matters: The deal gives the companies new potential assets as they prepare for Dupixent's patent cliff in 2031.